Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BRANCACCIO JOHN P Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/10/2022 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
12/03/2021 3 BRANCACCIO JOHN P (Director) has filed a Form 3 on Accustem Sciences Inc.
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 7,000 shares @ $1.53, valued at $10.7k
08/21/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 30,000 options @ $3.72, valued at $111.6k
06/19/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 28,858 options @ $2.6, valued at $75k
05/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
07/25/2019 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 970 options @ $3.24, valued at $3.1k
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2018 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 13,896 shares @ $0
Exercised 50,023 options @ $0.5, valued at $25k
07/03/2018 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Bought 3 convertible preferred @ $1000, valued at $3k
Bought 1,725 warrants @ $1.55, valued at $2.7k
06/19/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2018 4/A BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.
Txns: Bought 10,000 shares @ $0.8, valued at $8k
06/11/2018 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.
Txns: Bought 10,000 shares @ $0.8, valued at $8k
04/02/2018 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns: Exercised 50,000 options @ $0.5, valued at $25k
01/25/2018 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.
Txns: Granted 54,322 options @ $0.3, valued at $16.3k
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/20/2016 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
06/29/2016 4/A BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns: Granted 62,500 options @ $3.67, valued at $229.4k
06/27/2016 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns: Granted 62,500 options @ $3.67, valued at $229.4k
01/06/2016 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.
Txns: Granted 16,000 options @ $5.18, valued at $82.9k
07/28/2015 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns: Granted 37,000 options @ $7.91, valued at $292.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy